Hospitals, Health IT

Penn Medicine and Babyscripts partner to develop postpartum hypertension solution

The duo will utilize Babyscripts’ remote monitoring tech along with information gained from Penn Medicine’s Heart Safe Motherhood program.

Young African-American woman hugging and cuddling her baby boy or girl and nursing him. Mother embracing newborn son and expressing love and care. Modern illustration. Isolated. Vector.

Philadelphia-based Penn Medicine and Babyscripts, a startup providing tech-enabled tools for prenatal and postpartum care, have collaborated to develop a solution for the remote monitoring of patients with postpartum hypertension.

In addition to pinpointing those who need additional attention, the organizations will work to increase the number of blood pressure readings in the postpartum stage to catch rising blood pressure sooner, decrease the length of hospital stay and reduce readmissions after delivery.

presented by

To meet their goals, the duo will bring together Babyscripts’ remote monitoring tech with information gained from Penn Medicine’s Heart Safe Motherhood program, a remote text-based blood pressure monitoring program for postpartum patients who have been discharged from the hospital.

Based in Washington, D.C., Babyscripts offers remote monitoring technology to support high-risk pregnancies so physicians can better keep track of expectant moms. Patients get access to the startup’s mobile app and doctors can enroll them in one of the Babyscripts modules. Physicians receive patient data in real time and can intervene and alter individuals’ care pathways as needed.

In 2018, the company did a gestational diabetes study with North Carolina-based Cone Health. One hundred patients from the system’s Center for Women’s Healthcare had the option to sign up for the pilot study.

And earlier this year, the Washington, D.C. startup announced it raised $6 million in a round of financing led by Philips. NueCura Partners and StartUp Health also participated.

Regarding its collaboration with Penn Medicine, the company intends to take the care protocols and elements tested in HSM and translate them onto the Babyscripts platform to monitor women with postpartum hypertension.

“We are incredibly excited to partner with Penn Medicine to improve the management of patients after they deliver,” Babyscripts co-founder and president Juan Pablo Segura said in a statement. “This is another example of what Babyscripts uniquely brings to the table. For us, it’s not just technology tools. It’s protocols and best practices that have proven success. Our goal is completely redefining maternal care, this is another huge step towards eliminating complications.”

Photo: Lisitsa, Getty Images